Viking Therapeutics Inc (NAS:VKTX)
$ 58.88 2.65 (4.71%) Market Cap: 6.49 Bil Enterprise Value: 5.24 Bil PE Ratio: 0 PB Ratio: 6.95 GF Score: 38/100

Q4 2023 Viking Therapeutics Inc Earnings Call Transcript

Feb 07, 2024 / 09:30PM GMT
Release Date Price: $24.48 (-0.53%)
Operator

Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2023 financial results conference call. At this time, all participants are in a listen only mode. Following management's prepared remarks, we will hold a question and answer session to ask a question. At that time, please press the star key followed by one on your touchtone phone. If anyone has difficulty hearing the conference, please press star zero for operator assistance as a reminder, this conference call is being recorded today, February seventh, 2024.

I would now like to turn the conference over to Viking's Manager of Investor Relations, Stephanie Diaz, please go ahead.

Stephanie Diaz
Viking Therapeutics, Inc. - Manager of IR

Hello, and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO, and Greg Xantic, Viking's CFO.

Before we begin, I'd like to caution that comments made during this conference call today, February seventh, 2024, will contain forward-looking statements under the Safe Harbor provisions of the US

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot